-
1
Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis
Published 2016-09-01Subjects: “…lipoprotein(a) [lp(a)]…”
Get full text
Article -
2
High lipoprotein(a): Actionable strategies for risk assessment and mitigation
Published 2024-06-01Subjects: “…Lipoprotein(a) [Lp(a)]…”
Get full text
Article -
3
"APO(a) isoforms and LP(a) concentration in predicting risk for coronary artery disease: A study in men <55 years of age "
Published 2000-12-01Subjects: “…Lipoprotein(a) [LP(a)]…”
Get full text
Article -
4
"APO(a) isoforms and LP(a) concentration in predicting risk for coronary artery disease: A study in men <55 years of age "
Published 2000-11-01Subjects: “…Lipoprotein(a) [LP(a)]…”
Get full text
Article -
5
Lipoprotein(a): Role in atherosclerosis and new treatment options
Published 2023-07-01Subjects: “…Lipoprotein(a) (Lp(a))…”
Get full text
Article -
6
-
7
Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations
Published 2021-12-01Subjects: “…lipoprotein(a) [Lp(a)]…”
Get full text
Article